Geode Capital Management’s Crescent Biopharma, Inc. Common Stock CBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-5,717
| Closed | -$120K | – | 4474 |
|
|
2025
Q1 | $120K | Buy |
5,717
+505
| +10% | +$10.6K | ﹤0.01% | 3988 |
|
|
2024
Q4 | $130K | Hold |
5,212
| – | – | ﹤0.01% | 4027 |
|
|
2024
Q3 | $88.1K | Buy |
5,212
+340
| +7% | +$5.75K | ﹤0.01% | 4141 |
|
|
2024
Q2 | $137K | Sell |
4,872
-179
| -4% | -$5.04K | ﹤0.01% | 4037 |
|
|
2024
Q1 | $1.52M | Buy |
5,051
+262
| +5% | +$78.6K | ﹤0.01% | 3218 |
|
|
2023
Q4 | $1.13M | Buy |
4,789
+191
| +4% | +$45.1K | ﹤0.01% | 3309 |
|
|
2023
Q3 | $690K | Sell |
4,598
-164
| -3% | -$24.6K | ﹤0.01% | 3480 |
|
|
2023
Q2 | $829K | Buy |
4,762
+709
| +17% | +$123K | ﹤0.01% | 3428 |
|
|
2023
Q1 | $511K | Hold |
4,053
| – | – | ﹤0.01% | 3638 |
|
|
2022
Q4 | $1.23M | Buy |
4,053
+469
| +13% | +$142K | ﹤0.01% | 3262 |
|
|
2022
Q3 | $197K | Hold |
3,584
| – | – | ﹤0.01% | 4220 |
|
|
2022
Q2 | $214K | Sell |
3,584
-50
| -1% | -$2.99K | ﹤0.01% | 4215 |
|
|
2022
Q1 | $414K | Sell |
3,634
-17
| -0.5% | -$1.94K | ﹤0.01% | 4036 |
|
|
2021
Q4 | $525K | Sell |
3,651
-12
| -0.3% | -$1.73K | ﹤0.01% | 4018 |
|
|
2021
Q3 | $802K | Buy |
3,663
+136
| +4% | +$29.8K | ﹤0.01% | 3803 |
|
|
2021
Q2 | $818K | Sell |
3,527
-3,675
| -51% | -$852K | ﹤0.01% | 3706 |
|
|
2021
Q1 | $2.17M | Buy |
7,202
+473
| +7% | +$142K | ﹤0.01% | 3220 |
|
|
2020
Q4 | $2.53M | Buy |
6,729
+680
| +11% | +$256K | ﹤0.01% | 2952 |
|
|
2020
Q3 | $1.86M | Buy |
6,049
+655
| +12% | +$201K | ﹤0.01% | 2914 |
|
|
2020
Q2 | $2.03M | Buy |
5,394
+220
| +4% | +$82.7K | ﹤0.01% | 2828 |
|
|
2020
Q1 | $1.18M | Buy |
5,174
+270
| +6% | +$61.5K | ﹤0.01% | 2945 |
|
|
2019
Q4 | $2.59M | Sell |
4,904
-139
| -3% | -$73.5K | ﹤0.01% | 2846 |
|
|
2019
Q3 | $2.17M | Buy |
5,043
+370
| +8% | +$159K | ﹤0.01% | 2900 |
|
|
2019
Q2 | $5.57M | Buy |
4,673
+222
| +5% | +$265K | ﹤0.01% | 2319 |
|
|
2019
Q1 | $5.55M | Buy |
4,451
+331
| +8% | +$412K | ﹤0.01% | 2267 |
|
|
2018
Q4 | $3.9M | Buy |
4,120
+574
| +16% | +$543K | ﹤0.01% | 2372 |
|
|
2018
Q3 | $5.11M | Buy |
3,546
+293
| +9% | +$422K | ﹤0.01% | 2346 |
|
|
2018
Q2 | $5.25M | Buy |
3,253
+1,239
| +62% | +$2M | ﹤0.01% | 2297 |
|
|
2018
Q1 | $3.27M | Buy |
2,014
+444
| +28% | +$721K | ﹤0.01% | 2497 |
|
|
2017
Q4 | $2.64M | Hold |
1,570
| – | – | ﹤0.01% | 2605 |
|
|
2017
Q3 | $2.2M | Buy |
1,570
+112
| +8% | +$157K | ﹤0.01% | 2686 |
|
|
2017
Q2 | $1.63M | Buy |
1,458
+508
| +53% | +$567K | ﹤0.01% | 2849 |
|
|
2017
Q1 | $515K | Hold |
950
| – | – | ﹤0.01% | 3302 |
|
|
2016
Q4 | $579K | Buy |
950
+90
| +10% | +$54.9K | ﹤0.01% | 3218 |
|
|
2016
Q3 | $615K | Buy |
860
+40
| +5% | +$28.6K | ﹤0.01% | 3169 |
|
|
2016
Q2 | $595K | Buy |
820
+305
| +59% | +$221K | ﹤0.01% | 3150 |
|
|
2016
Q1 | $306 | Sell |
515
-1
| -0.2% | -$1 | ﹤0.01% | 3463 |
|
|
2015
Q4 | $294K | Buy |
516
+2
| +0.4% | +$1.14K | ﹤0.01% | 3518 |
|
|
2015
Q3 | $288K | Buy |
514
+1
| +0.2% | +$560 | ﹤0.01% | 3511 |
|
|
2015
Q2 | $408K | Buy |
513
+17
| +3% | +$13.5K | ﹤0.01% | 3290 |
|
|
2015
Q1 | $412K | Buy |
496
+20
| +4% | +$16.6K | ﹤0.01% | 3272 |
|
|
2014
Q4 | $342K | Buy |
476
+2
| +0.4% | +$1.44K | ﹤0.01% | 3355 |
|
|
2014
Q3 | $329K | Buy |
474
+90
| +23% | +$62.5K | ﹤0.01% | 3353 |
|
|
2014
Q2 | $323K | Sell |
384
-43
| -10% | -$36.2K | ﹤0.01% | 3348 |
|
|
2014
Q1 | $698K | Buy |
+427
| New | +$698K | ﹤0.01% | 2984 |
|